Skip to main content
. 2014 Dec 16;12:336. doi: 10.1186/s12967-014-0336-5

Table 4.

Analysis of product stability

Parameter Validation run TCF after enrichment 48 h 54 h 72 h
value recovery value recovery value recovery
WBC 1. run 1.43x107 9.60x106 67.00% 7.80x106 54.50% 7.60x106 53.10%
2. run 5.00x106 4.40x106 88.00% 4.20x106 84.00% 4.00x106 80.00%
3. run 1.25x107 8.60x106 69.00% 7.30x106 58.60% 6.50x106 51.70%
viable WBC 1. run 1.01x107 8.00x106 79.50% 7.20x106 71.60% 6.20x106 61.70%
2. run 3.40x106 3.20x106 94.10% 3.80x106 >100% 3.60x106 >100%
3. run 6.00x106 5.20x106 85.70% 4.30x106 71.40% 3.90x106 64.30%
viable T cells 1. run 1.74x106 1.42x106 81.61 1.32x106 75.86% 1.22x106 70.11%
2. run 2.97x106 2.17x105 73.06% 1.97x105 66.33% 2.49x105 83.84%
3. run 1.83x106 2.12x106 >100% 1.85x106 >100% 2.09x106 >100%

Stability of the cells from the T-cell fraction (TCF) was analysed after 48 h, 54 h and 72 h post-leukapheresis with respect to total numbers of WBCs [x106], viable WBCs [x106] viable T cells (CD3+CD56 T cells) [x106], and recovery [%]. Detection of total cell numbers and viability was performed by light microscopy using trypan blue dye.